|
The statistics are constantly changing as new drugs come out. Many of the
best known CML experts such as Dr. Talpaz at M.D. Anderson now consider CML to
be a chronic disease and that few patients in the future will die from CML
itself. Gleevec works well in the majority of patients and other new drugs
in the pipeline that are now in clinical trial are working well for
patients who have not responded to Gleevec.
Rob
|
- [CML] CCR after 3 months in Phase 2 BMS trial karen.andrews
- Re: [CML] CCR after 3 months in Phase 2 BMS trial Rob
- Re: [CML] CCR after 3 months in Phase 2 BMS trial livia klescova
- Re: [CML] CCR after 3 months in Phase 2 BMS trial Rob
- Re: [CML] CCR after 3 months in Phase 2 BMS tr... livia klescova
- Re: [CML] CCR after 3 months in Phase 2 BM... Rob
- [CML] Prognosis Skim
- Re: [CML] Prognosis Rob
- Re: [CML] CCR after 3 months in Phase 2 BMS trial Skim
